Antidepressant Use in Pregnancy: Risks and Recommendations
Medication Safety Profile
- Nortriptyline is a tricyclic antidepressant (TCA) that primarily increases norepinephrine levels in the brain, with less effect on serotonin compared to SSRIs, according to the American Academy of Child and Adolescent Psychiatry 1
- Limited data on specific risks of nortriptyline during pregnancy compared to other antidepressants, as reported by the American Academy of Child and Adolescent Psychiatry 1
Risks Associated with Antidepressant Use
- Possible increased risk of spontaneous abortion with nortriptyline use, though confounding by indication cannot be ruled out, as noted by the American College of Obstetricians and Gynecologists 2
- Potential for poor neonatal adaptation syndrome when nortriptyline is used late in pregnancy, as reported by the American Academy of Family Physicians 3
- Untreated depression during pregnancy is associated with adverse outcomes, including premature birth and decreased initiation of breastfeeding, according to the American Academy of Family Physicians 3
Clinical Considerations
- Medications with more pregnancy safety data might be preferable when starting new treatment, as suggested by the American Academy of Family Physicians 3
- Physiological changes in pregnancy may alter drug metabolism, potentially requiring dose adjustments, particularly in the third trimester, as reported by the American Journal of Obstetrics and Gynecology 2